IP Library Granted Patent US 12,672,947
Granted Patent B2
US 12,672,947 · App. 17/580,434 · Granted Jul 7, 2026

Prosthetic surgical sling

Inventors: Rebecca U. Ruefer (Bozeman, MT); Beda B. G. Ruefer (Bozeman, MT)
A61F2/0036A61F2/0045A61L31/048A61L31/06A61L31/146A61L31/16B29C48/0018B29C48/09B29D7/01A61F2002/0081A61F2240/001A61F2240/002A61L2300/406B29C43/24B29K2027/18B29L2031/7532
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,672,947
App. No.
17/580,434
Filed
Jan 20, 2022
Granted
Jul 7, 2026
Kind
B2
Art Unit
3791
USPC
600/30
Abstract

Disclosed is a process of making an expanded fluoropolymer, e.g., PTFE, article is disclosed. The article is formed from a PTFE resin, calendered, and then expanded (e.g., uniaxially, multiaxially, etc.) at an elevated temperature. After cooling, the article is used to form a surgically implanted device, e.g., a surgical prosthetic sling.

Claims (21)

1 . A surgical implant comprising:

an elongated flat implant body having first and second ends, the implant body being configured to support a body tissue, the body formed of a biocompatible, bacteria-resistant fluoropolymer material,

wherein the biocompatible, bacteria-resistant fluoropolymer material comprises a plurality of nodes and a plurality of fibrils, wherein the implant body is multiaxially expanded such that the plurality of fibrils radiate between the plurality of nodes to define a plurality of pores, each of the plurality of pores each having a length and a width, a smallest of the length or width being about equal to or less than about 2 micron, wherein more than about 80% of the implant body is comprised of solid nodes, and

wherein the biocompatible, bacteria-resistant fluoropolymer material comprises a microporous structure which is closed to ingrowth and bacterial penetration.

2 . The surgical implant of claim 1 , wherein the biocompatible, bacteria-resistant fluoropolymer material comprises Polytetrafluoroethylene (PTFE).

3 . The surgical implant of claim 2 , wherein the biocompatible, bacteria-resistant fluoropolymer material comprises expanded PTFE (ePTFE).

4 . The surgical implant of claim 1 , wherein the surgical implant is substantially microporous.

5 . The surgical implant of claim 1 , wherein the plurality of fibrils are about 0.5 to about 3 microns in length.

6 . The surgical implant of claim 1 , wherein the plurality of pores defined between the plurality of nodes and fibrils are less than or equal to 2 by 1 microns in size.

7 . The surgical implant of claim 1 , wherein the implant body has a thickness of about 0.60 mm.

8 . The surgical implant of claim 1 , wherein the surgical implant is configured for use as a pubovaginal sling.

9 . The surgical implant of claim 8 , wherein the first end is configured to receive a first surgical placement aid, and the second end is configured to receive a second surgical placement aid.

10 . The surgical implant of claim 1 , wherein the plurality of pores are about 0.5 microns to about 1.0 microns.

11 . The surgical implant of claim 1 , wherein the implant body is configured for organ engagement.

12 . The surgical implant of claim 1 , wherein the implant body is configured for the receipt of surgical placement aids.

13 . An expanded PTFE tissue-engaging surgical implant comprising

a body formed of expanded PTFE, the body having:

a microporous structure including a plurality of nodes and a plurality of multiaxially-radiating fibrils, the plurality of multiaxially-radiating fibrils radiate between the plurality of nodes to establish a plurality of pores, each of the plurality of pores having sizes which are less than or equal to about 2 microns, wherein more than about 80% of the body is comprised of solid nodes, and

the microporous structure being closed to ingrowth and bacterial penetration.

14 . The expanded PTFE tissue-engaging surgical implant of claim 13 , wherein the plurality of multiaxially-radiating fibrils have lengths from about 0.5 microns to about 1.0 microns.

15 . The expanded PTFE tissue-engaging surgical implant of claim 13 , having smooth edges which prevent damage upon implant.

Continuity (2)
Provisional Application 63140052 · Jan 21, 2021
Related Publication 20220226093A1 · Jul 21, 2022
References Cited (54)
US 3953566A · Gore · 1976 [cited by examiner]
US 4902423A · Bacino · 1990 [cited by examiner]
US 5112344A · Petros · 1992 [cited by applicant]
US 5433909A · Martakos · 1995 [cited by examiner]
US 5476589A · Bacino · 1995 [cited by applicant]
US 5899909A · Claren et al. · 1999 [cited by applicant]
US 5934283A · Willem · 1999 [cited by examiner]
US 6099791A · Shannon et al. · 2000 [cited by applicant]
US 6273852B1 · Lehe et al. · 2001 [cited by applicant]
US 6712919B2 · Ruefer et al. · 2004 [cited by applicant]
US 6953428B2 · Gellman · 2005 [cited by examiner]
US 7070558B2 · Gellman et al. · 2006 [cited by applicant]
US 8007430B2 · Browning · 2011 [cited by examiner]
US 8097007B2 · Evans et al. · 2012 [cited by applicant]
US 8123817B2 · Intoccia · 2012 [cited by examiner]
US 8628464B2 · Bourne et al. · 2014 [cited by applicant]
US 8765039B1 · Ledergerber · 2014 [cited by applicant]
US 8845512B2 · Evans · 2014 [cited by examiner]
US 9078728B2 · Chu · 2015 [cited by examiner]
US 12397139B1 · Sibary · 2025 [cited by examiner]
US 20020001705A1 · Ruefer et al. · 2002 [cited by applicant]
US 20020029011A1 · Dyer · 2002 [cited by applicant]
US 20030130670A1 · Anderson · 2003 [cited by examiner]
US 20050042250A1 · Damien et al. · 2005 [cited by applicant]
US 20050101834A1 · Merade · 2005 [cited by examiner]
US 20050234291A1 · Gingras · 2005 [cited by examiner]
US 20060217812A1 · Lambrecht · 2006 [cited by examiner]
US 20070152367A1 · Kramer et al. · 2007 [cited by applicant]
US 20070299538A1 · Roeber · 2007 [cited by applicant]
US 20080269547A1 · Hortenstine · 2008 [cited by examiner]
US 20090216338A1 · Gingras et al. · 2009 [cited by applicant]
US 20110184228A1 · Sherry et al. · 2011 [cited by applicant]
US 20120065649A1 · Towler · 2012 [cited by applicant]
US 20120239161A1 · Datta et al. · 2012 [cited by applicant]
US 20130030243A1 · Boden et al. · 2013 [cited by applicant]
US 20130204355A1 · Goldmann · 2013 [cited by examiner]
US 20130231733A1 · Knisley · 2013 [cited by examiner]
US 20140142368A1 · Arnal et al. · 2014 [cited by applicant]
US 20220226091A1 · Ruefer et al. · 2022 [cited by applicant]
US 20220226092A1 · Ruefer et al. · 2022 [cited by applicant]
US 20230363880A1 · Ruefer et al. · 2023 [cited by applicant]
CA 2864711C · 2013 [cited by applicant]
CN 119604254A · 2025 [cited by examiner]
EP 1214951A1 · 2002 [cited by applicant]
WO WO9747246A1 · 1997 [cited by examiner]
WO 2011098565A1 · 2011 [cited by applicant]
WO 2022159654A1 · 2022 [cited by applicant]
WO 2023224844A1 · 2023 [cited by applicant]
PCT Patent Application PCT/US2023/021601 International Search Report and Written Opinion dated Aug. 11, 2023. [cited by applicant]
Communication pursuant to Article 94(3) EPC issued May 30, 2025 in EP Application No. 22703516.9, 5 pages. [cited by applicant]
Falagas et al., “Mesh-related infections after pelvic organ prolapse repair surgery”, European Journal of Obstetrics & Gynecology and Reproductive Biology, Sep. 26, 2007, vol. 134, No. 2, pp. 147-156, ISSN: 0301-2115. [cited by applicant]
Baggish MS, Karram MM, eds. Atlas of Pelvic Anatomy and Gynecology Surgery, ed 3. St. Louis: Saunders; 2011. [cited by applicant]
PCT Patent Application PCT/US2022/013233 International Search Report and Written Opinion dated Apr. 28, 2022. [cited by applicant]
PCT Patent Application PCT/US2022/013235 International Search Report and Written Opinion dated May 2, 2022. [cited by applicant]